A 67-year-old man with a 4-year duration of insulinrequiring diabetes presented to our
diabetic retinopathy clinic. He was a nonsmoker, normotensive but required atorvastatin for …

Purpose After vitrectomy, diffusion and clearance rates of numerous drugs are increased,
leading to a shorter intravitreal half-life. This raises doubts about the efficacy of intravitreal …

Purpose: To assess the safety and efficacy of supra choroidal triamcinolone injection (SCT)
in cases of refractory diabetic macular oedema. Study Design: Interventional case series …

OBJECTIVE: To determine whether an intravitreal injection of triamcinolone acetonide for
persistent diabetic macular edema after adequate laser treatment improves visual acuity …

[Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection:
functional and anatomical outcomes]. - Abstract - Europe PMC Sign in | Create an account …

Objective To look for alterations of glycemic control as a secondary systemic effect of the
retrobulbar injection of triamcinolone acetonide in diabetic and non-diabetic patients …

Background Diabetic macular edema (DME) is the most common cause of loss of vision in
diabetic patients. The role of inflammation in the pathogenesis of DME has been …

Background/aims: The aim of this study was to compare the morphological and visual acuity
outcomes associated with a single intravitreal injection of triamcinolone acetonide versus …

PURPOSE: To present a case of severe drop in vision in both eyes caused by diabetic
papillopathy that was treated with an intravitreal injection of triamcinolone acetonide …

Purpose: To compare eyes that received treatment with untreated fellow eyes to assess the
effectiveness of injection of 20 mg of triamcinolone acetonide (TA) into the posterior sub …